Balancing CIK Cell Cancer Immunotherapy and PPAR Ligands: One Potential Therapeutic Application for CNS Malignancies

Balancing CIK Cell Cancer Immunotherapy and PPAR Ligands: One Potential Therapeutic Application for CNS Malignancies

ABSTRACT Background Cytokine‐induced killer (CIK) cell therapy has proven successful in clinical trials regarding glioblastoma. Equally important are the hints suggesting peroxisome proliferator‐activated receptors (PPARs) ligands being co‐expressed in the central nervous system (CNS). This provides...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kira Vordermark, JingJing Pu, Amit Sharma, Jarek Maciacyzk, Ingo G. H. Schmidt‐Wolf
Format:	Article
Language:	English
Published:	Wiley 2024-12-01
Series:	Cancer Medicine
Subjects:	cytokine‐induced killer cells glioblastoma neuroblastoma peroxisome proliferator‐activated receptors WNT/β‐catenin
Online Access:	https://doi.org/10.1002/cam4.70497
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Preclinical evaluation of DC-CIK cells as potentially effective immunotherapy model for the treatment of glioblastoma
by: Annika Simone Lück, et al.
Published: (2025-01-01)

Transcription factor YY1-activated GNG5 facilitates glioblastoma cell growth, invasion, stemness and glycolysis through Wnt/β-catenin pathway
by: Sheng Liang, et al.
Published: (2024-10-01)

Sacubitril/Valsartan partially alleviates myocardial infarction injury by activating the FGF21 signaling pathway via PPARs
by: Wenjuan Wei, et al.
Published: (2025-02-01)

Wnt-signaling pathway in pathogenesis of glioblastoma multiforme
by: Yu. D. Vasilets, et al.
Published: (2019-01-01)

PPARα deficiency exacerbates retinal pathological changes and dysfunction in high-fat diet mice
by: Xue Wang, et al.
Published: (2025-06-01)

POLE2 silencing inhibits the progression of colorectal carcinoma cells via wnt signaling axis
by: Weihua Jian, et al.
Published: (2024-12-01)

Low-intensity Pulsed Ultrasound Enhances NK Cell Adoptive Therapy by Modulating the Wnt/β-catenin Signaling Pathway
by: Renjie Feng, et al.
Published: (2025-07-01)

Pnky Modulates Neural Stem Cell Proliferation and Differentiation Through Activation of Wnt/β-Catenin Signaling Pathway
by: Haidong Wu, et al.
Published: (2025-12-01)

Overexpression of HACE1 in gastric cancer inhibits tumor aggressiveness by impeding cell proliferation and migration
by: Ying‐ling Chen, et al.
Published: (2018-06-01)

Bioinformatics analysis of duck PPARα gene structure and function
by: MA Yun, et al.
Published: (2011-07-01)

The expression of pro-prion, a transmembrane isoform of the prion protein, leads to the constitutive activation of the canonical Wnt/β-catenin pathway to sustain the stem-like phenotype of human glioblastoma cells
by: Alessandro Corsaro, et al.
Published: (2024-12-01)

Ultrasound therapy inhibits knee osteoarthritis progression in rabbits by activating the PPARs pathway: a pilot study
by: Qinglu Luo, et al.
Published: (2025-12-01)

PPARα regulates YAP protein levels and activity by affecting its ubiquitination modification
by: Wenhong Zhou, et al.
Published: (2025-02-01)

Inhibition of LINC01048 decreases cell proliferation and induces the apoptosis in gastric cancer
by: Jinxi Huang, et al.
Published: (2025-06-01)

CGREF1 modulates osteosarcoma proliferation by regulating the cell cycle through the Wnt/β-catenin signaling pathway
by: Zicheng Wei, et al.
Published: (2024-12-01)

RETRACTED ARTICLE: NR3C2 affects the proliferation and invasiveness of colon cancer cells through the Wnt/β-Catenin signaling pathway
by: Ke Nie, et al.
Published: (2024-09-01)

Elabela alleviates cuproptosis and vascular calcification in vitaminD3- overloaded mice via regulation of the PPAR-γ /FDX1 signaling
by: Rui-Qiang Qi, et al.
Published: (2024-11-01)

PGAM1: a potential therapeutic target mediating Wnt/β-catenin signaling drives breast cancer progression
by: Yongxuan Wang, et al.
Published: (2025-02-01)

Administration of chiglitazar reverses chronic stress-induced depressive-like symptoms in mice via activation of hippocampal PPARα and BDNF
by: Jiu-Jian Zhou, et al.
Published: (2025-04-01)

In silico and in vitro investigations reveal pan-PPAR agonist activity and anti-NAFLD efficacy of polydatin by modulating hepatic lipid-energy metabolism
by: Sumit Kumar Mandal, et al.
Published: (2025-07-01)

KLF1 Promotes Cardiomyocyte Proliferation and Heart Regeneration Through Regulation of Wnt/β‐Catenin Signaling Pathway
by: Yanglin Hao, et al.
Published: (2025-06-01)

Neogambogic Acid Suppresses Characteristics of Colorectal Cancer Stem Cells Through Inhibition of Wnt/β-catenin Signaling Pathway
by: Hao WANG, et al.
Published: (2025-07-01)

Relationship between Wnt/β-catenin signaling pathway and lupus nephritis
by: MA Xiao, et al.
Published: (2018-01-01)

Overview of Wnt/β-Catenin Pathway and DNA Damage/Repair in Cancer
by: Silvina B. Nadin, et al.
Published: (2025-02-01)

Naringin promotes osteoblast differentiation and ameliorates osteoporosis in ovariectomized mice
by: Yubo Cui, et al.
Published: (2025-04-01)

Empagliflozin improves pressure-overload-induced cardiac hypertrophy by inhibiting the canonical Wnt/β-catenin signaling pathway
by: Xun Yuan, et al.
Published: (2024-11-01)

NEK2 promotes cancer cell progression and 5-fluorouracil resistance via the Wnt/β-catenin signaling pathway in colorectal cancer
by: Facai Cui, et al.
Published: (2025-03-01)

Wnt/β-catenin signaling pathway role in the endometriosis pathogenesis
by: E. V. Virivskaya, et al.
Published: (2020-04-01)

SARTANS OF THE SECOND GENERATION: THERAPEUTIC POTENTIAL EXTENSION
by: S. V. Nedogoda
Published: (2016-01-01)

Expression study of Wnt/β-catenin signaling pathway associated lncRNAs in schizophrenia
by: Fatemeh Manafzadeh, et al.
Published: (2025-01-01)

Wnt Signaling Inhibitors as Therapeutic Approach in Ischemic Heart Disease
by: Barbora Boťanská Svetláková, et al.
Published: (2024-12-01)

MiR-499a-5p Promotes the Proliferation and Migration of Uterine Leiomyoma Cells by Activating the Wnt/&beta;-Catenin Signaling Pathway
by: Ni J, et al.
Published: (2025-07-01)

The Wnt signaling pathway: prospects for pharmacological regulation
by: V. V. Tatarskiy
Published: (2016-04-01)

Detection of the WNT/Beta-Catenin Signaling Activity by Using Immunocytochemical Technique in Cervical Smears
by: Hanife Güler Dönmez, et al.
Published: (2013-08-01)

KIN17 modulates the WNT/β-catenin pathway and epithelial mesenchymal transition in non-small cell lung cancer
by: Panli Peng, et al.
Published: (2025-07-01)

Selective PPARδ Agonist GW501516 Protects Against LPS-Induced Macrophage Inflammation and Acute Liver Failure in Mice via Suppressing Inflammatory Mediators
by: Hyun-Joung Lim, et al.
Published: (2024-11-01)

Per- and Polyfluoroalkyl Substances (PFAS) as Emerging Obesogens: Mechanisms, Epidemiological Evidence, and Regulatory Challenges
by: Niya Lewis, et al.
Published: (2024-12-01)

Identification and Functional Analysis of Novel Mutations in AXIN2 and LRP6 Linked With Non‐Syndromic Tooth Agenesis
by: Wendi Luo, et al.
Published: (2025-05-01)

The Dual Role and Therapeutic Implications of the Wnt/&beta;-Catenin Pathway in Diabetic Kidney Disease
by: Adeerjiang Y, et al.
Published: (2025-05-01)

CDCP1 promotes the malignant phenotypes of nasopharyngeal carcinoma via the Wnt/β-catenin signaling pathway
by: Guoliang Bie, et al.
Published: (2025-07-01)